DX41 (Diclofenac sodium extended-release 100 mg)
Pill imprint DX41 has been identified as Diclofenac sodium extended-release 100 mg.
Diclofenac is used in the treatment of back pain; muscle pain; frozen shoulder; sciatica; rheumatoid arthritis (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. There is positive evidence of human fetal risk during pregnancy. Diclofenac 100 mg is not a controlled substance under the Controlled Substance Act (CSA).
- 100 mg
- Prescription only
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- carnauba wax
ferric oxide red
|NDC Code||Manufacturer / Repackager|
|21695-0040||Rebel Distributors Corp (repackager)|
|66336-0383||Dispensing Solutions Inc. (repackager)|
Note: Inactive ingredients may vary.
More about diclofenac
- Diclofenac enteric-coated tablets
- Diclofenac extended-release tablets
- Diclofenac immediate-release tablets
- Diclofenac potassium powder packets
- More (2) »
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.